UK markets open in 7 hours 51 minutes
NIKKEI 225
38,079.70 +117.90 (+0.31%) HANG SENG
16,385.87 +134.03 (+0.82%) CRUDE OIL
82.59 -0.14 (-0.17%) GOLD FUTURES
2,393.90 -4.10 (-0.17%) DOW
37,775.38 +22.07 (+0.06%) Bitcoin GBP
51,090.18 +1,534.92 (+3.10%)
Infant Bacterial Therapeutics AB (publ) (IBT-B.ST)
Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
At close: 04:06PM CEST
Currency in SEK
Valuation measures4
| Market cap (intra-day) | 1.16B |
| Enterprise value | 829.48M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 3.80 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -6.78 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.01 |
| 52-week change 3 | 77.32% |
| S&P500 52-week change 3 | 21.61% |
| 52-week high 3 | 106.50 |
| 52-week low 3 | 41.30 |
| 50-day moving average 3 | 84.17 |
| 200-day moving average 3 | 87.26 |
Share statistics
| Avg vol (3-month) 3 | 6.94k |
| Avg vol (10-day) 3 | 6.35k |
| Shares outstanding 5 | 13.02M |
| Implied shares outstanding 6 | 13.47M |
| Float 8 | 11.79M |
| % held by insiders 1 | 8.89% |
| % held by institutions 1 | 49.02% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -174,827.27% |
Management effectiveness
| Return on assets (ttm) | -24.01% |
| Return on equity (ttm) | -38.65% |
Income statement
| Revenue (ttm) | 77k |
| Revenue per share (ttm) | 0.01 |
| Quarterly revenue growth (yoy) | -100.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -133.8M |
| Net income avi to common (ttm) | -123.07M |
| Diluted EPS (ttm) | -9.95 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 329.06M |
| Total cash per share (mrq) | 24.43 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 7.40 |
| Book value per share (mrq) | 22.65 |
Cash flow statement
| Operating cash flow (ttm) | -101.22M |
| Levered free cash flow (ttm) | -64.36M |
© 2024 Yahoo. All rights reserved.